<DOC>
	<DOCNO>NCT00549549</DOCNO>
	<brief_summary>This multicenter , double-blind , double-dummy , randomize , active-controlled study include 8-day treatment period follow 1-week follow-up period patient experience symptom acute exacerbation gouty arthritis .</brief_summary>
	<brief_title>Celebrex In Acute Gouty Arthritis Study</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Gouty</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>Acute gouty arthritis meeting American College Rheumatology ( ACR ) criterion acute arthritis primary gout ; Onset pain acute gouty arthritis attack within 48 hour prior Screening/Baseline ( Visit 1 ) ; A rating moderate , severe , extreme ( 2 , 3 , 4 , respectively ) Patient 's assessment pain intensity index joint ( 5point scale:04 ) Screening/Baseline . Diagnosis type arthritis include type suspect infectious origin index joint presence acute trauma index joint . Patients osteoarthritis include long mild moderate ( accord investigator 's criterion ) affect index joint ; Acute polyarticular gout involve great 4 joint chronic gout .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>